RNA polymerase II C-terminal domain required for enhancer-driven transcription

Nature. 1995 Apr 13;374(6523):660-2. doi: 10.1038/374660a0.

Abstract

The RNA polymerase II carboxy-terminal domain (CTD) consists of tandem repeats of the sequence Tyr-Ser-Pro-Thr-Ser-Pro-Ser. The CTD may participate in activated transcription through interaction with a high-molecular-weight mediator complex. Such a role would be consistent with observations that some genes are preferentially sensitive to CTD mutations. Here we investigate the function of the mouse RNA polymerase CTD in enhancer-driven transcription. Transcription by alpha-amanitin-resistant CTD-deletion mutants was tested by transient transfection of tissue culture cells in the presence of alpha-amanitin in order to inhibit endogenous RNA polymerase II. Removal of most of the CTD abolishes transcriptional activation by all enhancers tested, whereas transcription from promoters driven by Sp1, a factor that typically activates housekeeping genes from positions proximal to the initiation sites, is not affected. These findings show that the CTD is essential in mediating 'enhancer'-type activation of mammalian transcription.

MeSH terms

  • Amanitins / pharmacology
  • Amino Acid Sequence
  • Animals
  • Base Sequence
  • Cell Line
  • DNA / metabolism
  • Enhancer Elements, Genetic*
  • HeLa Cells
  • Humans
  • Mice
  • Molecular Sequence Data
  • RNA Polymerase II / antagonists & inhibitors
  • RNA Polymerase II / metabolism*
  • Sequence Deletion
  • Sp1 Transcription Factor / metabolism
  • Transcription, Genetic*
  • Transfection

Substances

  • Amanitins
  • Sp1 Transcription Factor
  • DNA
  • RNA Polymerase II